IRON - CIK 0001816736
The table below shows Disc Medicine, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $45.90M | $50.33M | $46.32M | $27.76M | $24.68M | $23.48M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $23.62M |
| $17.36M |
| $15.09M |
| $12.18M |
| $8.17M |
| $7.37M |
| Operating income | -$69.52M | -$67.70M | -$61.41M | -$39.95M | -$32.86M | -$30.85M |
| Income tax | $51.00K | $102.00K | $52.00K | $119.00K | $114.00K | $60.00K |
| Net income | -$63.50M | -$62.32M | -$55.25M | -$34.09M | -$26.60M | -$26.35M |
| EPS (diluted) | -$1.65 | -$1.77 | -$1.58 | -$1.02 | -$0.89 | -$1.03 |